These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20880612)

  • 21. 2,5-Disubstituted pyridines: the discovery of a novel series of 5-HT2A ligands.
    Wilson KJ; van Niel MB; Cooper L; Bloomfield D; O'Connor D; Fish LR; MacLeod AM
    Bioorg Med Chem Lett; 2007 May; 17(9):2643-8. PubMed ID: 17314044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
    Caliendo G; Fiorino F; Perissutti E; Severino B; Gessi S; Cattabriga E; Borea PA; Santagada V
    Eur J Med Chem; 2001; 36(11-12):873-86. PubMed ID: 11755230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT2C receptor agonists as an innovative approach for psychiatric disorders.
    Rosenzweig-Lipson S; Dunlop J; Marquis KL
    Drug News Perspect; 2007 Nov; 20(9):565-71. PubMed ID: 18176661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity relationship of 2-(aminoalkyl)-2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine derivatives: a novel series of 5-HT(2A/2C) receptor antagonists. Part 2.
    Andrés JI; Alcázar J; Alonso JM; Díaz A; Fernández J; Gil P; Iturrino L; Matesanz E; Meert TF; Megens A; Sipido VK
    Bioorg Med Chem Lett; 2002 Jan; 12(2):249-53. PubMed ID: 11755365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding.
    Kanagarajadurai K; Malini M; Bhattacharya A; Panicker MM; Sowdhamini R
    Mol Biosyst; 2009 Dec; 5(12):1877-88. PubMed ID: 19763327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.
    Chambers JJ; Parrish JC; Jensen NH; Kurrasch-Orbaugh DM; Marona-Lewicka D; Nichols DE
    J Med Chem; 2003 Jul; 46(16):3526-35. PubMed ID: 12877591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand dependency of 5-hydroxytryptamine 2C receptor internalization.
    Schlag BD; Lou Z; Fennell M; Dunlop J
    J Pharmacol Exp Ther; 2004 Sep; 310(3):865-70. PubMed ID: 15113845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
    Bubar MJ; Cunningham KA
    Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
    J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression.
    Berg KA; Harvey JA; Spampinato U; Clarke WP
    Prog Brain Res; 2008; 172():287-305. PubMed ID: 18772038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.
    Labrecque J; Fargin A; Bouvier M; Chidiac P; Dennis M
    Mol Pharmacol; 1995 Jul; 48(1):150-9. PubMed ID: 7623769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.
    Egan C; Grinde E; Dupre A; Roth BL; Hake M; Teitler M; Herrick-Davis K
    Synapse; 2000 Feb; 35(2):144-50. PubMed ID: 10611640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonists.
    Forbes IT; Dabbs S; Duckworth DM; Ham P; Jones GE; King FD; Saunders DV; Blaney FE; Naylor CB; Baxter GS; Blackburn TP; Kennett GA; Wood MD
    J Med Chem; 1996 Dec; 39(25):4966-77. PubMed ID: 8960557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
    Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods.
    Bissantz C; Schalon C; Guba W; Stahl M
    Proteins; 2005 Dec; 61(4):938-52. PubMed ID: 16224780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of constitutive 5-hydroxytryptamine(1B) receptor by a series of mutations in the BBXXB motif: positioning of the third intracellular loop distal junction and its G(o)alpha protein interactions.
    Pauwels PJ; Gouble A; Wurch T
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):435-42. PubMed ID: 10510311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists.
    Bray JK; Goddard WA
    J Mol Graph Model; 2008 Aug; 27(1):66-81. PubMed ID: 18499489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 5-HT2C receptor as a target for mood disorders.
    Serretti A; Artioli P; De Ronchi D
    Expert Opin Ther Targets; 2004 Feb; 8(1):15-23. PubMed ID: 14996615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug discovery targeting human 5-HT(2C) receptors: residues S3.36 and Y7.43 impact ligand-binding pocket structure via hydrogen bond formation.
    Canal CE; Cordova-Sintjago TC; Villa NY; Fang LJ; Booth RG
    Eur J Pharmacol; 2011 Dec; 673(1-3):1-12. PubMed ID: 22020288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.